Overall rank by patents
#320
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Sanofi-Aventis Deutschland GMBH
USPTO PatentsView assignee record — 1,348 granted patents across 89 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
1,348
Total patents granted
89
CPC technology areas
16.3
Avg claims per patent
-32%
5-year filing velocity
Portfolio overview
Sanofi-Aventis Deutschland GMBH has been granted 1,348 US utility patents between 2015 and 2025, placing Sanofi-Aventis Deutschland GMBH at rank #320 across all assignees tracked by PlainPatent. This portfolio spans 89 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.3 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Sanofi-Aventis Deutschland GMBH is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 63.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 546 grants, compared with 802 in the 2015–2019 window — a -32% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Sanofi-Aventis Deutschland GMBH's 16.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 89 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Sanofi-Aventis Deutschland GMBH against peers pursuing similar technology classes.
How does Sanofi-Aventis compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Sanofi-aventis De… ◀ 1,348
Sanofi-Aventis Deutschland GMBH
1,348 patents
What this shows Sanofi-Aventis holds 1,348 patents — placing it at rank #320 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 121 | 9.0% |
| 2016 | 217 | 16.1% |
| 2017 | 184 | 13.6% |
| 2018 | 113 | 8.4% |
| 2019 | 167 | 12.4% |
| 2020 | 126 | 9.3% |
| 2021 | 108 | 8.0% |
| 2022 | 94 | 7.0% |
| 2023 | 65 | 4.8% |
| 2024 | 66 | 4.9% |
| 2025 | 87 | 6.5% |
Which technologies does Sanofi-Aventis Deutschland GMBH patent most?
Top 15 of 89 technology areas
Patent Moat Analysis
Portfolio Volume Strong
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Sanofi-Aventis Deutschland GMBH hold?
Sanofi-Aventis Deutschland GMBH holds 1,348 US granted patents filed between 2015 and 2025, spanning 89 technology areas.
What is Sanofi-Aventis Deutschland GMBH's Innovation Score?
Sanofi-Aventis Deutschland GMBH has an Innovation Score of 63.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Sanofi-Aventis Deutschland GMBH focus on?
Sanofi-Aventis Deutschland GMBH's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 1,159 patents. The company has filed patents in 89 CPC subclasses total.
Is Sanofi-Aventis Deutschland GMBH's patent filing rate increasing or decreasing?
Sanofi-Aventis Deutschland GMBH's recent filing velocity is -32% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Sanofi-Aventis Deutschland GMBH's patents?
Sanofi-Aventis Deutschland GMBH's patents average 16.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the Sanofi-Aventis Deutschland GMBH patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
A61M technology
Sanofi-Aventis Deutschland GMBH's primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Sanofi-Aventis Deutschland GMBH ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
